Literature DB >> 18418677

Magnetic resonance imaging in spinocerebellar ataxias.

Susanne Döhlinger1, Till-Karsten Hauser, Johannes Borkert, Andreas R Luft, Jörg B Schulz.   

Abstract

Magnetic resonance (MR) imaging is widely used to visualize atrophic processes that occur during the pathogenesis of spinocerebellar ataxias (SCAs). T1-weighted images are utilized to rate the atrophy of cerebellar vermis, cerebellar hemispheres, pons and midbrain. Signal changes in the basal ganglia and ponto-cerebellar fibers are evaluated by T2-weighted and proton density-weighted images. However, two-dimensional (2D) images do not allow a reliable quantification of the degree of atrophy. The latter is now possible through the application of three-dimensional (3D) true volumetric methods, which should be used for research purposes. Ideally, these methods should allow automated segmentation of contrast-defined boundaries by using region growing algorithms, which can be applied successfully in structures of the posterior fossa and basal ganglia. Thin slice thickness helps to minimize partial volume effects. Whereas volumetric approaches rely on predetermined anatomical boundaries, voxel-based morphometry has been developed to determine group differences between different types of SCA (cross-sectional studies) or within one SCA entity (longitudinal studies). We will review recent results and how these methods are currently used to (i) separate sporadic and dominantly inherited forms of cerebellar ataxias; (ii) identify specific SCA genotypes; (iii) correlate patho-anatomical changes with SCA disease symptoms or severity; and (iv) visualize and estimate the rate of progression in SCA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418677     DOI: 10.1007/s12311-008-0025-0

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  65 in total

1.  Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3.

Authors:  K Bürk; M Abele; M Fetter; J Dichgans; M Skalej; F Laccone; O Didierjean; A Brice; T Klockgether
Journal:  Brain       Date:  1996-10       Impact factor: 13.501

2.  Characteristic signal changes in the pontine base on T2- and multishot diffusion-weighted images in spinocerebellar ataxia type 1.

Authors:  M Adachi; T Kawanami; H Ohshima; T Hosoya
Journal:  Neuroradiology       Date:  2005-10-19       Impact factor: 2.804

3.  A necropsied case of Machado-Joseph disease with a hyperintense signal of transverse pontine fibres on long TR sequences of magnetic resonance images.

Authors:  Y Imon; S Katayama; H Kawakami; Y Murata; M Oka; S Nakamura
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

4.  Autosomal dominant sensory/motor neuropathy with Ataxia (SMNA): Linkage to chromosome 7q22-q32.

Authors:  Zoran Brkanac; Magali Fernandez; Mark Matsushita; Hilary Lipe; John Wolff; Thomas D Bird; Wendy H Raskind
Journal:  Am J Med Genet       Date:  2002-05-08

5.  New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.

Authors:  Stephan Klebe; Alexandra Durr; Alexander Rentschler; Valerie Hahn-Barma; Michael Abele; Naima Bouslam; Ludger Schöls; Pierre Jedynak; Sylvie Forlani; Elodie Denis; Christel Dussert; Yves Agid; Peter Bauer; Christoph Globas; Ullrich Wüllner; Alexis Brice; Olaf Riess; Giovanni Stevanin
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

6.  Characteristic magnetic resonance imaging findings in Machado-Joseph disease.

Authors:  Y Murata; S Yamaguchi; H Kawakami; Y Imon; H Maruyama; T Sakai; T Kazuta; T Ohtake; M Nishimura; T Saida; S Chiba; T Oh-i; S Nakamura
Journal:  Arch Neurol       Date:  1998-01

7.  Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds.

Authors:  L Schöls; R Krüger; G Amoiridis; H Przuntek; J T Epplen; O Riess
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

8.  Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study.

Authors:  Carsten Lukas; Ludger Schöls; Barbara Bellenberg; Udo Rüb; Horst Przuntek; Gebhard Schmid; Odo Köster; Boris Suchan
Journal:  Neurosci Lett       Date:  2006-09-26       Impact factor: 3.046

9.  SCA-12: Tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion.

Authors:  E O'Hearn; S E Holmes; P C Calvert; C A Ross; R L Margolis
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

10.  A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23.

Authors:  Ming-Yi Chung; Yi-Chun Lu; Nai-Chia Cheng; Bing-Wen Soong
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

View more
  21 in total

1.  Genetics of ataxias: hereditary forms.

Authors:  N Tirada; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-12-26       Impact factor: 3.825

2.  Consensus paper: radiological biomarkers of cerebellar diseases.

Authors:  Leonardo Baldarçara; Stuart Currie; M Hadjivassiliou; Nigel Hoggard; Allison Jack; Andrea P Jackowski; Mario Mascalchi; Cecilia Parazzini; Kathrin Reetz; Andrea Righini; Jörg B Schulz; Alessandra Vella; Sara Jane Webb; Christophe Habas
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

Review 3.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

Review 4.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

5.  Cerebral gray matter volume losses in essential tremor: A case-control study using high resolution tissue probability maps.

Authors:  Eric Cameron; Jonathan P Dyke; Nora Hernandez; Elan D Louis; Ulrike Dydak
Journal:  Parkinsonism Relat Disord       Date:  2018-03-10       Impact factor: 4.891

6.  Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Cerebellum       Date:  2009-09       Impact factor: 3.847

7.  Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy.

Authors:  Gülin Oz; Isabelle Iltis; Diane Hutter; William Thomas; Khalaf O Bushara; Christopher M Gomez
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

8.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

Review 9.  Conventional MRI findings in hereditary degenerative ataxias: a pictorial review.

Authors:  Sirio Cocozza; Giuseppe Pontillo; Giovanna De Michele; Martina Di Stasi; Elvira Guerriero; Teresa Perillo; Chiara Pane; Anna De Rosa; Lorenzo Ugga; Arturo Brunetti
Journal:  Neuroradiology       Date:  2021-03-17       Impact factor: 2.804

10.  Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

Authors:  A Matilla-Dueñas; T Ashizawa; A Brice; S Magri; K N McFarland; M Pandolfo; S M Pulst; O Riess; D C Rubinsztein; J Schmidt; T Schmidt; D R Scoles; G Stevanin; F Taroni; B R Underwood; I Sánchez
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.